ECRIN is providing trial management support to three new projects coordinated by Spain: LIVERHOPE, HIVACAR, and ORTHOUNION.
Press release: Towards better medicines for children: PedCRIN project builds research infrastructure
PARIS (31 January 2017) – The European Clinical Research Infrastructure Network (ECRIN) has announced the launch of the Paediatric Clinical Research Infrastructure Network (PedCRIN).
The Clinical Research Initiative for Global Health (CRIGH) was officially launched on January 1st, 2017.
New Clinical Trials
In 2016, ECRIN received funding for 11 new clinical trials: six from Horizon 2020, one from the Innovative Medicines Initiative (IMI), and four from E-Rare, a European Research Area Network (ERA-Net) for research programmes on rare diseases.
The ECRIN Data Centre Certification programme identifies non-commercial clinical trial units (CTUs) demonstrating that they can provide safe, secure, compliant and efficient management of clinical research data. Here we highlight the current opportunities to expand this programme beyond Europe.
A new paper has been published on an ECRIN-supported trial, DISCHARGE: "Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial".
ECRIN's Director General, Jacques Demotes, discusses the potential transformative impact of multinational clinical trials in this interview with Pan European Networks.
Steve Canham and Christian Ohmann recently published a methodology piece in Trials proposing standards for consistent descriptions of repositories for storing the data and documents created by clinica
The CORBEL (Coordinated Research Infrastructures Building Enduring Life-science services) project has launched an "Open Call" to invite researchers to access technologies and services from more than 15 facilities from eight different research infrastructures (RIs) across Europe.
The kick-off meeting for the Clinical Research Initiative for Global Health (CRIGH) was held from 12 to 13 October in Paris, France.
Eudipharm, OrphanDev and ECRIN’s French national partner, F-CRIN, have teamed up to organise a training session on orphan drugs and rare diseases. The event will be held from 17 to 18 November 2016 in Marseille, France.
ECRIN has contributed to a publication entitled “Publicly funded practice-oriented clinical trials: of importance for healthcare payers”.
ECRIN received a positive funding decision from the European Commission’s Horizon 2020 programme for the creation of a Paediatric Clinical Research Infrastructure Network (PedCRIN).
ECRIN’s Portuguese national scientific partner has authored a new publication entitled “Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN).”
ReveraGen BioPharma Inc Initiates VISION-DMD Phase 2a Study for Treatment of Duchenne Muscular Dystrophy
Enrolment has begun in the phase 2a clinical trial of the orphan drug vamorolone (VBP15) in the treatment of ambulatory boys with Duchenne muscular dystrophy (DMD).
ECRIN’s Independent Certification Board certified two clinical trial units (CTUs) as high-quality data centres in July 2016.
ECRIN signed a memorandum of understanding (MoU) in July 2016 with the Foundation for Biomedical Research and Innovation (FBRI) in Japan and the Oswaldo Cruz Foundation (Fundacao Oswaldo Cruz, FIOCRUZ) in Brazil.
ECRIN's Director General, Jacques Demotes, provides a brief report on this year's celebration of International Clinical Trials Day (ICTD).
The FAIR-PARK II trial (Conservative Iron Chelation as a Disease-Modifying Strategy in Parkinson's Disease, PD) has held site initiation visits at all participating sites in France (sponsor country). The first patient was enrolled in February 2016.